APA aipamena

Xu, Y., Ding, L., Tian, Y., Bi, M., Han, N., & Wang, L. (2021). Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis. Front Oncol.

Chicago Style aipamena

Xu, Yangchun, Lei Ding, Yuan Tian, Miaomiao Bi, Ning Han, and Ling Wang. "Comparative Efficacy and Safety of PARP Inhibitors As Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis." Front Oncol 2021.

MLA aipamena

Xu, Yangchun, et al. "Comparative Efficacy and Safety of PARP Inhibitors As Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis." Front Oncol 2021.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.